Fennec Pharmaceuticals (FENC) Interest Coverage Ratio (2014 - 2025)
Fennec Pharmaceuticals (FENC) posted Interest Coverage Ratio of 1.07 for Q4 2025, down 231.61% on a QoQ basis from 0.32 in Q3 2025, and down 10.62% year-over-year from 1.2 in Q4 2024.
Fennec Pharmaceuticals (FENC) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 1.07 for Q4 2025.
- Quarterly Interest Coverage Ratio fell 10.62% year-over-year to 1.07 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.51 (down 339.31% YoY) and the FY2025 annual result came in at 0.14, down 375.4% from the prior year.
- Interest Coverage Ratio was 1.07 for Q4 2025 at Fennec Pharmaceuticals, down from 0.32 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 13.29 in Q1 2024 and bottomed at 1230.75 in Q1 2021.
- A 5-year average of 83.43 and a median of 5.37 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio plunged 63064.22% — and 2024, when it surged 301.26%.
- Fennec Pharmaceuticals' Interest Coverage Ratio stood at 67.85 in 2021, then surged by 87.85% to 8.25 in 2022, then surged by 75.9% to 1.99 in 2023, then jumped by 51.34% to 0.97 in 2024, then retreated by 10.62% to 1.07 in 2025.
- Business Quant data shows FENC's Interest Coverage Ratio at 1.07 in Q4 2025, 0.32 in Q3 2025, and 4.6 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | -1.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.07 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -4.60 |
| Mar 31, 2025 | -1.36 |
| Dec 31, 2024 | -0.97 |
| Sep 30, 2024 | -5.08 |
| Jun 30, 2024 | -4.83 |
| Mar 31, 2024 | 13.29 |
| Dec 31, 2023 | -1.99 |
| Sep 30, 2023 | -1.19 |
| Jun 30, 2023 | -5.66 |
| Mar 31, 2023 | -6.60 |
| Dec 31, 2022 | -8.25 |
| Sep 30, 2022 | -45.14 |
| Jun 30, 2022 | -87.88 |
| Mar 31, 2022 | -61.14 |
| Dec 31, 2021 | -67.85 |
| Sep 30, 2021 | -75.87 |
| Jun 30, 2021 | -71.27 |
| Mar 31, 2021 | -1,230.75 |